FALLS CHURCH, Va. (PRWEB)
January 06, 2021
Develop World-Class SOPs that Minimize Human Error
An FDAnews Webinar
Wednesday, Jan. 13, 2021, 1:00-2:30 p.m. EST
https://www.fdanews.com/sophumanerror
Looking to improve an organization’s productivity, quality and regulatory success? Standard operating procedures (SOPs) are key.
Most regulatory citations are related to procedures. And procedures account for more than 40% of human error events in manufacturing. By improving SOPs, one will minimize both human error and regulatory citations.
How does one go about it?
Human Error Solutions’ CEO, Ginette Collazo, Ph.D. — an Industrial-Organizational Psychologist and one of the world’s few human error reduction experts — will explain:
-
How to prepare an outline and develop world-class SOPs - The interrelationship between SOPs, quality and regulatory compliance
- Why human error is a root cause for lack of quality and how to minimize it
- Common mistakes and causes of human error
- How to create and maintain a procedure that minimizes human error
- Good procedure writing practices: terminology, formats, layouts, mixed cases, steps content, familiar words, references, branching, conditional steps and the use of precautions, warnings and cautions
- Use of electronic information networks for procedural access
While human error may never be eliminated completely, attendees will come away with clear guidance to help one have SOPs that minimize such issues to avoid human error events and regulatory citations.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Develop World-Class SOPs that Minimize Human Error
An FDAnews Webinar
Wednesday, Jan. 13, 2021, 1:00-2:30 p.m. EST
https://www.fdanews.com/sophumanerror
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/sophumanerror
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations
Share article on social media or email: